EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+1.57%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.61B
AUM Growth
+$36.4M
(+2.3%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19
Top Buys
| 1 |
ASE Group
ASX
|
$25.3M |
| 2 |
Microsoft
MSFT
|
$12.9M |
| 3 |
NVIDIA
NVDA
|
$11.9M |
| 4 |
Apple
AAPL
|
$9.18M |
| 5 |
Amazon
AMZN
|
$7.47M |
Top Sells
| 1 |
Sea Limited
SE
|
$24.3M |
| 2 |
Advanced Micro Devices
AMD
|
$16.8M |
| 3 |
TSMC
TSM
|
$8M |
| 4 |
Weibo
WB
|
$2.43M |
| 5 |
Pinduoduo
PDD
|
$2.4M |
Sector Composition
| 1 | Consumer Discretionary | 40.2% |
| 2 | Technology | 29.79% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 5.71% |
| 5 | Real Estate | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
CareDx
CDNA
$697M
| $183K | 0.01% |
17,239
+7,074
| +70% | +$74.9K |
|
352
Relay Therapeutics
RLAY
$690M
| $182K | 0.01% |
21,930
+4,444
| +25% | +$36.9K |
|
|
CDMO
353
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $166K | 0.01% |
24,837
+4,488
| +22% | +$30.1K |
|
354
Allogene Therapeutics
ALLO
$246M
| $166K | 0.01% |
+37,130
| New | +$166K |
|
|
DCPH
355
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $162K | 0.01% |
+10,313
| New | +$162K |
|
356
Anavex Life Sciences
AVXL
$804M
| $161K | 0.01% |
31,659
+19,271
| +156% | +$98.1K |
|
357
Olema Pharmaceuticals
OLMA
$436M
| $158K | 0.01% |
+13,927
| New | +$158K |
|
358
MannKind Corp
MNKD
$1.64B
| $157K | 0.01% |
34,596
-9,025
| -21% | -$40.9K |
|
359
Caribou Biosciences
CRBU
$172M
| $132K | 0.01% |
25,586
+5,235
| +26% | +$26.9K |
|
360
Summit Therapeutics
SMMT
$17.7B
| $127K | 0.01% |
+30,729
| New | +$127K |
|
361
SiriusXM
SIRI
$7.94B
| $125K | 0.01% |
3,214
-90
| -3% | -$3.49K |
|
362
MiMedx Group
MDXG
$1.05B
| $105K | 0.01% |
+13,622
| New | +$105K |
|
363
Tango Therapeutics
TNGX
$760M
| $82.6K | 0.01% |
+10,398
| New | +$82.6K |
|
364
Alector
ALEC
$285M
| $78.4K | ﹤0.01% |
13,025
+2,833
| +28% | +$17.1K |
|
365
Mersana Therapeutics
MRSN
$35.5M
| $78K | ﹤0.01% |
+696
| New | +$78K |
|
366
Scilex Holding
SCLX
$142M
| $50K | ﹤0.01% |
898
| – | – |
|
367
Boeing
BA
$174B
| – | – |
-768
| Closed | -$200K |
|
368
Alibaba
BABA
$312B
| – | – |
-4,488
| Closed | -$348K |
|
369
Baidu
BIDU
$33.8B
| – | – |
-4,578
| Closed | -$545K |
|
|
BLUE
370
DELISTED
bluebird bio
BLUE
| – | – |
-3,503
| Closed | -$96.7K |
|
371
Day One Biopharmaceuticals
DAWN
$759M
| – | – |
-12,618
| Closed | -$184K |
|
|
DQ
372
Daqo New Energy
DQ
$1.81B
| – | – |
-50,735
| Closed | -$1.35M |
|
373
Futu Holdings
FUTU
$26.3B
| – | – |
-18,944
| Closed | -$1.03M |
|
374
Structure Therapeutics
GPCR
$1.14B
| – | – |
-28,589
| Closed | -$1.17M |
|
|
HSAI
375
Hesai Group
HSAI
$3.51B
| – | – |
-170,914
| Closed | -$1.52M |
|